Conference item icon

Conference item : Poster

Magrolimab + azacitidine versus azacitidine + placebo in untreated higher risk (HR) myelodysplastic syndromes (MDS): the Phase 3, randomized, ENHANCE Study

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


Publisher:
Elsevier
Journal:
Clinical Lymphoma, Myeloma and Leukemia More from this journal
Volume:
21
Issue:
S1
Pages:
S230
Publication date:
2021-08-30
Acceptance date:
2021-03-30
Event title:
9th Annual Meeting of the Society of Hematologic Oncology (SOHO 2021)
Event location:
https://www.soho2021.com/soho2021/home
Event start date:
2021-09-08
Event end date:
2021-09-11
DOI:
EISSN:
2152-2669
ISSN:
2152-2650
Language:
English
Keywords:
Subtype:
Poster
Pubs id:
1196514
Local pid:
pubs:1196514
Deposit date:
2021-12-09

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP